#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine adenocarcinoma Gastric cancer Anti-myelin-associated glycoprotein associated polyneuropathy Neurodegenerative disorder Immune-mediated enterocolitis Cardiomyopathy Amyotrophic lateral sclerosis gene carrier Dedifferentiated liposarcoma Mantle cell lymphoma recurrent Non-small cell lung cancer recurrent Cystic fibrosis lung Leiomyosarcoma Cystic fibrosis Primary adrenal insufficiency Metastases to central nervous system More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome – Treatment Carcinoid syndrome – Diagnostics Medulloblastoma recurrent – Trials in Disease Stevens-Johnson syndrome – Diagnostics CADASIL – Basic Information Fragile X syndrome – Basic Information Stevens-Johnson syndrome – Life with Disease Hereditary optic atrophy – Trials in Disease CADASIL – Life with Disease Gastrointestinal stromal tumour – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lisinopril Navtemadlin Flortaucipir (18F) Dapagliflozin Propanediol Xenon (129Xe) Vatiquinone GSKVX000000070965 Betamethasone Dipropionate Abc-35B-116 Etoposide Phosphate Digoxin Immune Fab (Ovine) Tinengotinib ZINC Acasunlimab ZODASIRAN Cimetidine Hydrochloride Carbamazepine (Ph. Eur.) XYLOMETAZOLINE HYDROCHLORIDE Dipyridamole Staphylococcus Aureus More therapies…

    Learn about Your Condition

    Cervix carcinoma stage III Toxic nodular goitre Wheezing Hypochromic anaemia Paraesthesia Post procedural hypotension Bone marrow failure Epicondylitis Knee arthroplasty Coronary artery bypass Persistent depressive disorder K-ras gene mutation Extraskeletal ossification Breast cancer stage I Osteomyelitis acute More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neoplasm

  • Study on Everolimus and Drug Combination for Children with Relapsed or Refractory Pediatric Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Futibatinib
    • Peposertib
    • Enasidenib Mesilate
    Denmark France Italy The Netherlands Spain

  • Study of SAR445877 and Cetuximab for Adults with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Kd050
    • Cetuximab
    The Netherlands Spain

  • Study on Long-Term Safety of BI 907828 for Patients with Solid Tumors Who Previously Participated in a Study with This Medicine

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • (3S,3’S,3A’s,10A’s)-6-Chloro-3′-(3-Chloro-2-Fluorophenyl)-1′-(Cyclopropylmethyl)-6′-Methyl-2-Oxo-1,2,3′,3A’,10′,10A’-Hexahydro-1’H-Spiro[Indole-3,2′-Pyrrolo[2′,3′:4,5]Pyrrolo[1,2-B]Indazole]-7′-Carboxylic Acid
    Belgium Czechia Denmark France Germany Hungary +5

  • Study on the Safety and Effectiveness of ART0380 Alone or with Gemcitabine or Irinotecan for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Art0380 Mesilate
    • Gemcitabine Hydrochloride
    • Irinotecan Hydrochloride
    France Spain

  • Study on the Safety and Effects of IPN01195 in Adults with Advanced Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • IPN01195
    France Italy Spain

  • Study on the Safety and Effectiveness of Zilovertamab Vedotin for Children and Young Adults with Blood Cancers or Solid Tumors

    Recruiting

    1 1 1
    Investigated Diseases:
    • Haematological malignancy
    • Neoplasm
    Investigated Drugs:
    • Zilovertamab Vedotin
    Belgium Czechia Denmark France Germany Greece +6
Previous Page
1 … 9 10 11 12 13 … 25
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!